Veraxa Biotech AG VRXA 深 沪
已收盘 09-25 16:00:00 美东时间
1.41
0.000
0.00%
华盛通- 最 高1.45
- 今 开1.43
- 成交量 5.58万股
- 最 低 1.382
- 昨 收 1.41
- 总市值 1.99亿
- 52周最高 27.36
- 市盈率 静 4.96
- 换手率 0.04%
- 52周最低 1.27
- 委 比 62.71%
- 总股本 1.41亿
- 历史最高 27.36
- 量 比 1.45
- 振 幅 4.82%
- 历史最低 1.27
- 每 手 1
- 风险率 4.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多VERAXA Biotech names Raju Willener as CFO
VERAXA (VRXA) said on Friday it appointed Raju Willener as CFO, effective immediately, succeeding Carl von Halem, former CFO. Willener brings more than 30 years of international experience across inve...
09-04 19:07
VERAXA Biotech Announces Initial Results From Strategic Research Collaboration To Develop Next-Generation Antibody Oligonucleotide Conjugates For Autoimmune And Chronic Immune Diseases; In Early In Vitro Studies, An AOC Candidate Demonstrated Greater Potency
VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in the design and development of next-generation cancer therapeutics, and Secarna Pharmaceuticals GmbH & Co. KG ("Secarna"), a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announc...
08-24 19:10
VERAXA Biotech (NASDAQ: VRXA) Shareholders Approve Corporate Governance, Financing Measures
Austin, Texas, United States, July 28th, 2026, FinanceWire VERAXA Biotech (NASD...
07-29 01:00
VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration
Austin, Texas, United States, July 27th, 2026, FinanceWire VERAXA Biotech (NASD...
07-28 02:30
VERAXA Biotech AG (NASDAQ: VRXA) Appoints Christoph Erkel as Chief Scientific Officer
Austin, Texas, United States, July 24th, 2026, FinanceWire VERAXA Biotech (NASD...
07-25 01:00
VERAXA Gets German Regulatory Feedback On Cancer Therapy Plan
VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA))), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the Paul-Ehrlich-Institute (PEI), regarding the underlying biology and proposed non-clinical development pl...
07-20 19:09
VERAXA Biotech appoints interim CFO
VERAXA Biotech (VRXA) appointed Carl von Halem as interim chief financial officer, succeeding Torsten Bürgermeister Carl von Halem currently serves as CFO of Xlife Sciences and played a key role in VE...
07-11 04:11
VERAXA Biotech Appoints Carl Von Halem As Interim CFO, Succeeding Torsten Bürgermeister
VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA"))), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer. He succeeds Torsten Bürgermeister. The company is currently in the final stages of discussions with a highly qual...
07-11 04:06
Penguin Solutions, Beazer Homes, Alibaba And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. Shares of Penguin Solutions Inc (NASDAQ:PENG) rose sharply after the company announced better-than-expected third-quarter financial results. Penguin reported adjusted earnings per share of 84 cents, beating ...
07-08 22:18
美股牛股 | 制药企业CRNX股价狂飙近99%！获福泰制药百亿美元高溢价收购；罕见病药物研究公司AGIO涨18%
制药企业CRNX股价狂飙近99%！获福泰制药百亿美元高溢价收购；罕见病药物研究公司AGIO涨18%，核心产品新药申请获FDA受理；基因治疗药物研发企业NGNE涨13%，公司成功完成新一轮融资>>
07-08 19:19
